$0.00110
0.000.00%
At close: -
$0.00160
0.0005045.45%
After Hours: May 27, 9:12 AM EDT
Comments
Loading...
CNBX Pharmaceuticals Analyst Ratings and Price Targets | OTC:CNBX | Benzinga
CNBX Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for CNBX Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for CNBX Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for CNBX Pharmaceuticals (CNBX) stock?
There is no price target for CNBX Pharmaceuticals
What is the most recent analyst rating for CNBX Pharmaceuticals (CNBX)?
There is no analyst for CNBX Pharmaceuticals
When was the last upgrade for CNBX Pharmaceuticals (CNBX)?
There is no last upgrade for CNBX Pharmaceuticals
When was the last downgrade for CNBX Pharmaceuticals (CNBX)?
There is no last downgrade for CNBX Pharmaceuticals.
When is the next analyst rating going to be posted or updated for CNBX Pharmaceuticals (CNBX)?
There is no next analyst rating for CNBX Pharmaceuticals.
Is the Analyst Rating CNBX Pharmaceuticals (CNBX) correct?
There is no next analyst rating for CNBX Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
